Biosimilar Newsletter Archive

1. 01.14.21 -- Will These Big Biosimilar Questions Be Answered In 2021? 1/14/2021
   01/14/21 Biosimilar Development Newsletter
2. 01.13.21 -- New Year, New Podcast Episodes: Clinical Trials During A Pandemic; Gene Therapies At Scale 1/13/2021
   01/13/21 Biosimilar Development Newsletter
3. 01.07.21 -- Biosimilars In 2021 And Beyond 1/7/2021
   01/07/21 Biosimilar Development Newsletter
4. 12.22.20 -- Biosimilar Development Top 10 Of 2020 12/22/2020
   12/22/20 Biosimilar Development Newsletter
5. 12.18.20 -- Cytiva's Greatest Hits For Gene Therapy -- 2020 Edition 12/18/2020
   12/18/20 Biosimilar Development Newsletter
6. 12.17.20 -- 2020's Greatest Biosimilar Achievements 12/17/2020
   12/17/20 Biosimilar Development Newsletter
7. 12.11.20 -- Best Of 2020 - Process Development Efficiency And Outcomes 12/11/2020
   12/11/20 Biosimilar Development Newsletter
8. 12.10.20 -- Why Severability Should Be In Your Biosimilar Vocabulary 12/10/2020
   12/10/20 Biosimilar Development Newsletter
9. 12.08.20 -- New Podcast Episodes: 2021 Trends For Biotech, Modulation Of The Microbiome And Biopharma Financing 12/8/2020
   12/08/20 Biosimilar Development Newsletter
10. 12.03.20 -- 3 Perspectives On Biosimilars & Biobetter Development 12/3/2020
    12/03/20 Biosimilar Development Newsletter